"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT01883297 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01883297
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Platinum-resistant High Grade Serous Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2015-01-01
Primary completion: 2027-06-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.